Sen, Sukanta. “Canagliflozin (Invokana®): A First-in-Class Anti-Diabetic Drug”. Journal of Drug Delivery and Therapeutics 3, no. 3 (May 13, 2013): 145-146. Accessed September 19, 2019. http://www.jddtonline.info/index.php/jddt/article/view/490.